615 related articles for article (PubMed ID: 18292563)
1. Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.
Li W; Murthy AK; Guentzel MN; Seshu J; Forsthuber TG; Zhong G; Arulanandam BP
J Immunol; 2008 Mar; 180(5):3375-82. PubMed ID: 18292563
[TBL] [Abstract][Full Text] [Related]
2. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele.
Murthy AK; Cong Y; Murphey C; Guentzel MN; Forsthuber TG; Zhong G; Arulanandam BP
Infect Immun; 2006 Dec; 74(12):6722-9. PubMed ID: 17015458
[TBL] [Abstract][Full Text] [Related]
3. A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice.
Li W; Murthy AK; Lanka GK; Chetty SL; Yu JJ; Chambers JP; Zhong G; Forsthuber TG; Guentzel MN; Arulanandam BP
Vaccine; 2013 Nov; 31(48):5722-8. PubMed ID: 24096029
[TBL] [Abstract][Full Text] [Related]
4. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
[TBL] [Abstract][Full Text] [Related]
5. Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection.
Cong Y; Jupelli M; Guentzel MN; Zhong G; Murthy AK; Arulanandam BP
Vaccine; 2007 May; 25(19):3773-80. PubMed ID: 17349723
[TBL] [Abstract][Full Text] [Related]
6. The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells.
Murphey C; Murthy AK; Meier PA; Neal Guentzel M; Zhong G; Arulanandam BP
Cell Immunol; 2006 Aug; 242(2):110-7. PubMed ID: 17116296
[TBL] [Abstract][Full Text] [Related]
7. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
[TBL] [Abstract][Full Text] [Related]
8. Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells.
Yu H; Karunakaran KP; Kelly I; Shen C; Jiang X; Foster LJ; Brunham RC
J Immunol; 2011 Mar; 186(6):3615-21. PubMed ID: 21296978
[TBL] [Abstract][Full Text] [Related]
9. Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach.
Li W; Guentzel MN; Seshu J; Zhong G; Murthy AK; Arulanandam BP
Clin Vaccine Immunol; 2007 Dec; 14(12):1537-44. PubMed ID: 17942608
[TBL] [Abstract][Full Text] [Related]
10. Endogenous IFN-gamma production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice.
Jupelli M; Guentzel MN; Meier PA; Zhong G; Murthy AK; Arulanandam BP
J Immunol; 2008 Mar; 180(6):4148-55. PubMed ID: 18322226
[TBL] [Abstract][Full Text] [Related]
11. Antigen-Specific CD4
Lin H; He C; Koprivsek JJ; Chen J; Zhou Z; Arulanandam B; Xu Z; Tang L; Zhong G
Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30962403
[TBL] [Abstract][Full Text] [Related]
12. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.
Hansen J; Jensen KT; Follmann F; Agger EM; Theisen M; Andersen P
J Infect Dis; 2008 Sep; 198(5):758-67. PubMed ID: 18652549
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T cells reduce the tissue burden of Chlamydia muridarum in male BALB/c mice.
Cunningham KA; Carey AJ; Timms P; Beagley KW
Vaccine; 2010 Jul; 28(31):4861-3. PubMed ID: 20653101
[TBL] [Abstract][Full Text] [Related]
14. Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge.
Chaganty BK; Murthy AK; Evani SJ; Li W; Guentzel MN; Chambers JP; Zhong G; Arulanandam BP
Vaccine; 2010 Mar; 28(11):2323-9. PubMed ID: 20056182
[TBL] [Abstract][Full Text] [Related]
15. Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice.
Yu H; Karunakaran KP; Jiang X; Shen C; Andersen P; Brunham RC
Infect Immun; 2012 Apr; 80(4):1510-8. PubMed ID: 22290151
[TBL] [Abstract][Full Text] [Related]
16. The role of an enzymatically inactive CPAF mutant vaccination in Chlamydia muridarum genital tract infection.
Chen H; Peng B; Yang C; Xie L; Zhong S; Sun Z; Li Z; Wang C; Liu X; Tang X; Zhong G; Lu C
Microb Pathog; 2021 Nov; 160():105137. PubMed ID: 34390765
[TBL] [Abstract][Full Text] [Related]
17. Intranasal vaccination with Chlamydia pneumoniae induces cross-species immunity against genital Chlamydia muridarum challenge in mice.
Manam S; Chaganty BK; Evani SJ; Zafiratos MT; Ramasubramanian AK; Arulanandam BP; Murthy AK
PLoS One; 2013; 8(5):e64917. PubMed ID: 23741420
[TBL] [Abstract][Full Text] [Related]
18. Nonpathogenic Colonization with Chlamydia in the Gastrointestinal Tract as Oral Vaccination for Inducing Transmucosal Protection.
Wang L; Zhu C; Zhang T; Tian Q; Zhang N; Morrison S; Morrison R; Xue M; Zhong G
Infect Immun; 2018 Feb; 86(2):. PubMed ID: 29133348
[No Abstract] [Full Text] [Related]
19. Immunization with a combination of integral chlamydial antigens and a defined secreted protein induces robust immunity against genital chlamydial challenge.
Li W; Murthy AK; Guentzel MN; Chambers JP; Forsthuber TG; Seshu J; Zhong G; Arulanandam BP
Infect Immun; 2010 Sep; 78(9):3942-9. PubMed ID: 20605976
[TBL] [Abstract][Full Text] [Related]
20. Antigen specific immune response in Chlamydia muridarum genital infection is dependent on murine microRNAs-155 and -182.
Gupta R; Arkatkar T; Keck J; Koundinya GK; Castillo K; Hobel S; Chambers JP; Yu JJ; Guentzel MN; Aigner A; Christenson LK; Arulanandam BP
Oncotarget; 2016 Oct; 7(40):64726-64742. PubMed ID: 27556515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
